Targeted inhibition of the hepatitis C internal ribosomal entry site genomic RNA with oligonucleotide conjugates.

Abstract : Hepatitis C is a major public health concern, with an estimated 170 million people infected worldwide and an urgent need for new drug development. An attractive therapeutic approach is to prevent the 'cap-independent' translation initiation of the viral proteins by interfering with both the structure and function of the hepatitis C viral internal ribosomal entry site (HCV IRES). Towards this goal, we report the design, synthesis and purification of novel bi-functional molecules containing DNA or RNA antisenses attached to functional groups performing RNA hydrolysis. These 5' or 3'-coupled conjugates bind the HCV IRES with affinity and specificity and elicit targeted hydrolysis of the viral genomic RNA after short (1 h) incubation at low (500 nM) concentration at 37 degrees C in vitro. Additional secondary cleavage sites are induced and their mapping within the RNA structure indicates that functional domains IIIb-e are excised from the IRES that, based on cryo-EM studies, becomes incapable of binding the small ribosomal subunit and initiation factor 3 (eIF3). All these molecules inhibit, in a dose-dependent manner, the 'IRES-dependent' translation in vitro. The 5'-coupled imidazole conjugate reduces viral protein synthesis by half at a 300 nM concentration (IC50), corresponding to a 4-fold increase of activity when compared to the naked oligonucleotide. These new conjugates are now being tested for activity on infected hepatic cell lines.
Type de document :
Article dans une revue
Nucleic Acids Research, Oxford University Press, 2007, 35 (20), pp.6778-87. 〈10.1093/nar/gkm770〉
Liste complète des métadonnées

Littérature citée [43 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00709784
Contributeur : Annick Lefevre <>
Soumis le : mardi 19 juin 2012 - 14:36:08
Dernière modification le : vendredi 25 mai 2018 - 01:27:08
Document(s) archivé(s) le : jeudi 20 septembre 2012 - 02:31:23

Fichier

NAR2007.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Citation

Valérie Guerniou, Reynald Gillet, Fabienne Berrée, Bertrand Carboni, Brice Felden. Targeted inhibition of the hepatitis C internal ribosomal entry site genomic RNA with oligonucleotide conjugates.. Nucleic Acids Research, Oxford University Press, 2007, 35 (20), pp.6778-87. 〈10.1093/nar/gkm770〉. 〈inserm-00709784〉

Partager

Métriques

Consultations de la notice

291

Téléchargements de fichiers

123